• Slide
  • Slide
  • Slide

It includes global leaders, among the best experts in the field of lipid and cardivascular diseases


Dr. Renee Benghozi is an international clinical specialist in the development of pharmaceutical products for the treatment of cardiovascular and metabolic diseases. She has spent more than fifteen years at F. Hoffmann-La Roche Ltd. where she was recently the International Medical Director. Her past career in clinical medicine and her substantial experience in the pharmaceutical industry with the cardiology patients are also extremely valuable regarding her critical management role in drug development at Cerenis.

Furthermore, the Steering Committee gathers a prestigious internationally recognized team:

NichollsDr. Stephen Nicholls, Principal Investigator, appointed to lead SAHMRI’s Heart Health Research Theme Team (South Australian Health & Medical Research Institute, Adelaide, Australia), Professor of Cardiology at the University of Adelaide and Consultant Cardiologist, Royal Adelaide Hospital.

KasteleinDr. John Kastelein, professor of medicine, chairman of the department of vascular medicine, Strategic Chair of Genetics in Cardiovascular Disease at the Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.

MerkelyDr. Béla Merkely, Chairman at Semmelweis University Heart and Vascular Center, Head of the Laboratory of Hemodynamics – Saint George Hospital of the County of Fejér, Budapest, Hungary.

NissenDr. Steven Nissen, Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute, Cleveland, USA.

KausikDr. Kausik Ray, Professor of Cardiovascular Disease Prevention in the Division of Cardiovascular Sciences at St George’s Hospital, University of London, Honorary Consultant Cardiologist at St George’s Hospital NHS Trust, London, United Kingdom. 

SchwartzDr. Gregory Schwartz, Professor of Medicine Chief, Cardiology Section, at the Veterans Affairs Medical Center, Denver, USA.

Dr. Stephen Worthley, Head of the Cardiovascular Research Centre at the University of Adelaide and Helpman Professor of Cardiovascular Medicine, Adelaide, Australia.


Cerenis Therapeutics Holding SA
265 rue de la Découverte - Bât. A
31670 Labège, France
Tél. : +33 (0) 5 62 24 97 06
Fax : +33 (0) 5 62 19 04 17

Email: info@cerenis.com

Cerenis Therapeutics Inc
401 W Morgan Road
Ann Arbor, MI  48108
Phone +1 (734) 769-1110
Fax +1 (734) 769-1132